BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35655116)

  • 1. Seeking optimization of LT4 treatment in patients with differentiated thyroid cancer.
    Stramazzo I; Capriello S; Antonelli A; Fallahi P; Centanni M; Virili C
    Hormones (Athens); 2022 Dec; 21(4):537-543. PubMed ID: 35655116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Levothyroxine Sodium Soft Gelatin Capsules in Thyroidectomized Patients Taking Proton Pump Inhibitors: An Open-Label Study.
    Sachmechi I; Lucas KJ; Stonesifer LD; Ansley JF; Sack P; Celi FS; Scarsi C; Lanzi G; Wartofsky L; Burman KD
    Thyroid; 2023 Dec; 33(12):1414-1422. PubMed ID: 37885233
    [No Abstract]   [Full Text] [Related]  

  • 3. Assesment of attainment of recommended TSH levels and levothyroxine compliance in differentiated thyroid cancer patients.
    Yavuz DG; Yazan CD; Hekimsoy Z; Aydin K; Gokkaya N; Ersoy C; Akalın A; Topaloglu O; Aydogan BI; Dilekci ENA; Alphan Uc Z; Cansu GB; Ozsari L; Iyidir OT; Olgun ME; Keskin L; Mert M; Can B; Gungor K; Galip T; Cantürk Z; Elbuken G; Pekkolay Z; Kutbay NO; Yorulmaz G; Kalkan AT; Unsal YA; Yay A; Karagun B; Bozkur E
    Clin Endocrinol (Oxf); 2022 Dec; 97(6):833-840. PubMed ID: 35639050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease.
    Ito M; Kawasaki M; Danno H; Kohsaka K; Nakamura T; Hisakado M; Yoshioka W; Kasahara T; Kudo T; Nishihara E; Fukata S; Nishikawa M; Nakamura H; Miyauchi A
    Thyroid; 2019 Oct; 29(10):1364-1370. PubMed ID: 31411123
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal.
    Van Tassell B; Wohlford GF; Linderman JD; Smith S; Yavuz S; Pucino F; Celi FS
    Thyroid; 2019 Oct; 29(10):1371-1379. PubMed ID: 31364488
    [No Abstract]   [Full Text] [Related]  

  • 6. EVALUATION OF TREATMENT OF CENTRAL HYPOTHYROIDISM VERSUS PRIMARY HYPOTHYROIDISM IN RELATION TO LEVOTHYROXINE REPLACEMENT DOSE.
    Zeni D; Rissetti G; Ongaratti B; Pereira-Lima JF; Rech CGSL; Oliveira MDC
    Endocr Pract; 2019 Jul; 25(7):663-668. PubMed ID: 30865544
    [No Abstract]   [Full Text] [Related]  

  • 7. Triiodothyronine alongside levothyroxine in the management of hypothyroidism?
    Gottwald-Hostalek U; Kahaly GJ
    Curr Med Res Opin; 2021 Dec; 37(12):2099-2106. PubMed ID: 34553643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ITALIAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS STATEMENT-REPLACEMENT THERAPY FOR PRIMARY HYPOTHYROIDISM: A BRIEF GUIDE FOR CLINICAL PRACTICE.
    Guglielmi R; Frasoldati A; Zini M; Grimaldi F; Gharib H; Garber JR; Papini E
    Endocr Pract; 2016 Nov; 22(11):1319-1326. PubMed ID: 27482609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes within the thyroid axis after long-term TSH-suppressive levothyroxine therapy.
    Verburg FA; Smit JW; Grelle I; Visser TJ; Peeters RP; Reiners C
    Clin Endocrinol (Oxf); 2012 Apr; 76(4):577-81. PubMed ID: 22017394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Long-Term Combination LT4 and LT3 Therapy for Improving Hypothyroidism and Overall Quality of Life.
    Tariq A; Wert Y; Cheriyath P; Joshi R
    South Med J; 2018 Jun; 111(6):363-369. PubMed ID: 29863229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma.
    Lee J; Yun MJ; Nam KH; Chung WY; Soh EY; Park CS
    Thyroid; 2010 Feb; 20(2):173-9. PubMed ID: 20151824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart Failure and Stroke Risks in Users of Liothyronine With or Without Levothyroxine Compared with Levothyroxine Alone: A Propensity Score-Matched Analysis.
    Yi W; Kim BH; Kim M; Kim J; Im M; Ryang S; Kim EH; Jeon YK; Kim SS; Kim IJ
    Thyroid; 2022 Jul; 32(7):764-771. PubMed ID: 35570696
    [No Abstract]   [Full Text] [Related]  

  • 13. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
    Jonklaas J; Davidson B; Bhagat S; Soldin SJ
    JAMA; 2008 Feb; 299(7):769-77. PubMed ID: 18285588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is a Normal TSH Synonymous With "Euthyroidism" in Levothyroxine Monotherapy?
    Peterson SJ; McAninch EA; Bianco AC
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4964-4973. PubMed ID: 27700539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levothyroxine Cessation After Thyroid Lobectomy for Papillary Thyroid Cancer Can Be Achieved at the Same Rate as that for Benign Tumors Regardless of the Duration of Thyroid-stimulating Hormone Suppression.
    Na YM; Cho JS; Park MH
    Anticancer Res; 2021 Nov; 41(11):5713-5721. PubMed ID: 34732444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid levothyroxine improves thyroid control in patients with different hypothyroidism aetiology and variable adherence - case series and review.
    Ruchała M; Bossowski A; Brzozka MM; Gietka-Czernel M; Hubalewska-Dydejczyk A; Kos-Kudła B; Lewiński A; Syrenicz A; Zgliczyński W
    Endokrynol Pol; 2022; 73(5):893-902. PubMed ID: 36621916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of either LT4 monotherapy or LT4/LT3 combined therapy in patients totally thyroidectomized for thyroid cancer.
    Regalbuto C; Maiorana R; Alagona C; Paola RD; Cianci M; Alagona G; Sapienza S; Squatrito S; Pezzino V
    Thyroid; 2007 Apr; 17(4):323-31. PubMed ID: 17465862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levothyroxine Therapy in Thyrodectomized Patients.
    Miccoli P; Materazzi G; Rossi L
    Front Endocrinol (Lausanne); 2020; 11():626268. PubMed ID: 33584551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily requirement of softgel thyroxine is independent from gastric juice pH.
    Virili C; Capriello S; Stramazzo I; Brusca N; Santaguida MG; Gargano L; Bagaglini MF; Bruno G; Severi C; Centanni M
    Front Endocrinol (Lausanne); 2022; 13():1002583. PubMed ID: 36225208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Resistance to Exogenous Thyroxine in Humans.
    Lacámara N; Lecumberri B; Barquiel B; Escribano A; González-Casado I; Álvarez-Escolá C; Aleixandre-Blanquer F; Morales F; Alfayate R; Bernal-Soriano MC; Miralles R; Yildirim Simsir I; Özgen AG; Bernal J; Berbel P; Moreno JC
    Thyroid; 2020 Dec; 30(12):1732-1744. PubMed ID: 32498666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.